Curative Versus Non‐Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact
Cancer Reports · 2026-11 · 9 (11)
DOI: 10.1002/cnr2.70768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 16.11.2026. Verfasst von Anna Mantas und 10 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recurrence after curative‐intent resection for hepatocellular carcinoma (HCC) is common. Not all recurrences are clinically equivalent, as some remain amenable to curative treatment.
Aims
This study aimed to evaluate the clinical impact of curatively versus noncuratively treatable first recurrence on postrecurrence survival and to identify factors associated with noncurative first recurrence after HCC resection. Methods and Results We retrospectively analyzed patients undergoing curative‐intent resection for HCC at University Hospital Essen between 2009 and 2024. First recurrence was classified as curatively treatable (re‐resection, liver transplantation, or ablation) or noncurative (locoregional palliative therapy, systemic therapy, or best supportive care). Among 324 resected patients, 169 displayed recurrence, of which 63 (37.3%) had a curatively treatable first recurrence, while 106 (62.7%) presented with noncurative recurrence. Postrecurrence survival (PRS) differed markedly between groups: median PRS was 78 months following curative recurrence vs. 22 months following noncurative recurrence. In multivariable Cox regression, noncurative first recurrence was associated with impaired PRS (HR 3.51, 95% CI 2.04–6.02, p < 0.001). In multivariable logistic regression among patients with recurrence, elevated preoperative CRP (OR 2.13, 95% CI 1.02–4.47, p = 0.045) was associated with noncurative first recurrence, although this finding was sensitive to predictor specification.
Conclusion
Most first recurrences after curative‐intent HCC resection are not amenable to curative treatment. Survival after noncurative recurrence is markedly inferior, while baseline clinical and pathological variables poorly predict curative treatability. These findings highlight the clinical relevance of distinguishing curatively from noncuratively treatable first recurrence and suggest that noncurative recurrence may represent a complementary endpoint to conventional RFS in future studies.
Zitieren
APA
Mantas, A., Lueong, S. S., Dropmann, M., Starck, A., Hoyer, D. P., Schmitz, S. M., Heise, D., Ulmer, T. F., Siveke, J., Neumann, U. P., & Bednarsch, J. (2026). Curative Versus Non‐Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact. Cancer Reports, 9(11). https://doi.org/10.1002/cnr2.70768
Vancouver
Mantas A, Lueong SS, Dropmann M, Starck A, Hoyer DP, Schmitz SM, et al. Curative Versus Non‐Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact. Cancer Reports. 2026;9(11). doi:10.1002/cnr2.70768
BibTeX
@article{Mantas2026,
author = {Mantas, Anna and Lueong, Smiths S. and Dropmann, Marlene and Starck, Anne and Hoyer, Dieter P. and Schmitz, Sophia M. and Heise, Daniel and Ulmer, Tom F. and Siveke, Jens and Neumann, Ulf P. and Bednarsch, Jan},
title = {Curative Versus Non‐Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/cnr2.70768}
}
EUVIMED